NANOG and central nervous system cancer: The HH-GLI signaling was also shown to activate stemness-related transcription factors, such as NANOG, OCT4, SOX2, and BMI1 in gliomas [188], while its inhibition reduces NANOG expression, decreases cell proliferation and colony formation, and abolishes cisplatin resistance in OC cells [189].